- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
Clinical Trials on 신생물, 기저 세포 in Norway
총 1740 건
-
Active Biotech AB완전한
-
University of BergenUllevaal University Hospital; Helse Stavanger HF; St. Olavs Hospital; Helse Fonna; University... 그리고 다른 협력자들모병
-
University Hospital of North NorwayUniversity of Tromso; The Research Council of Norway완전한
-
Nordic Lymphoma GroupAmgen완전한
-
St. Olavs HospitalKarolinska Institutet; Oslo University Hospital; University Hospital of North Norway; Sahlgrenska... 그리고 다른 협력자들모병
-
Norwegian University of Science and TechnologyThe Research Council of Norway; Nordic Myeloma Study Group, Germany완전한
-
Pharmacyclics LLC.Janssen, LP완전한
-
University Hospital of North NorwayOdense University Hospital; Oslo University Hospital; Rigshospitalet, Denmark; University of... 그리고 다른 협력자들모집하지 않고 적극적으로
-
Oslo University HospitalHelse Sor-Ost모집하지 않고 적극적으로
-
Oslo University Hospital모병
-
Karolinska University HospitalThe Swedish Research Council; University of Leipzig모병
-
Norwegian University of Science and TechnologyThe Royal Norwegian Ministry of Health완전한
-
Trio Medicines Ltd.Norwegian University of Science and Technology종료됨
-
University Hospital of North Norway완전한
-
Ullevaal University Hospital완전한
-
Norwegian Breast Cancer Group완전한
-
Lund University HospitalCelgene; Janssen, LP; Nordic Lymphoma Group완전한재발성/불응성 맨틀 세포 림프종핀란드, 덴마크, 스웨덴, 노르웨이
-
University of AarhusNordic Lymphoma Group완전한
-
St. Olavs HospitalNorwegian University of Science and Technology완전한
-
Oslo University HospitalTargovax ASA모병
-
Haukeland University HospitalBerGenBio ASA완전한
-
Norwegian University of Science and TechnologyOslo University Hospital; St. Olavs Hospital완전한
-
Haukeland University HospitalKarolinska University Hospital; Oslo University Hospital; University Hospital of North Norway 그리고 다른 협력자들모병정상피종 | 고환 생식 세포 암 | 비정상피종 고환암 | 1기 고환암 | 2기 고환암 | 3기 고환암 | 4기 고환암 | 재발 고환암노르웨이, 스웨덴
-
Oslo University Hospital알려지지 않은
-
Oslo University Hospital알려지지 않은
-
Norwegian University of Science and TechnologySt. Olavs Hospital완전한
-
Oslo University HospitalAstraZeneca모집하지 않고 적극적으로암 | NSCLC | 비소세포폐암 | NSCLC, 3기 | 비소세포폐암 III기노르웨이, 핀란드, 리투아니아, 에스토니아
-
Oslo University HospitalNorwegian Cancer Society; Norwegian Foundation for Health and Rehabilitation종료됨
-
Oslo University Hospital완전한
-
Oslo University HospitalNorwegian Cancer Society; South-Eastern Norway Regional Health Authority모집하지 않고 적극적으로
-
Oslo University HospitalMassachusetts General Hospital; Dana-Farber Cancer Institute; University Medical Center Groningen 그리고 다른 협력자들모집하지 않고 적극적으로
-
Oslo University Hospital모병대장 간 전이가 있고 종양 부담이 심한 환자를 위한 HAI-Floxuridine 또는 Liver-Tx와 2차 화학요법의 병용과 2차 화학요법 단독 비교. (EXCALIBUR1+2)대장암 | 화학 요법 효과 | 간 전이노르웨이
-
Norwegian School of Sport SciencesUniversity of Oslo; Oslo University Hospital; University of Copenhagen; Université de Nantes; Syddansk Universitet, Denmark완전한
-
Oslo University HospitalUniversity of Oslo; Helse Stavanger HF; Haukeland University Hospital; St. Olavs Hospital; University...모병
-
Oslo University Hospital모집하지 않고 적극적으로
-
Nykode Therapeutics ASAMerck Sharp & Dohme LLC모병HNSCC | HPV 관련 편평 세포 암종프랑스, 노르웨이, 스페인, 영국, 헝가리, 폴란드, 체코, 독일
-
Oslo University HospitalThe Research Council of Norway완전한